NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

The North America dermatological therapeutics market is estimated to project a CAGR of 7.40% during the forecast period, 2019-2028. The region encompasses a highly fragmented dermatology industry, and is estimated to get consolidated as a result of complexity and rising costs. Also, there is a rising demand for dermatology services. The United States and Canada are evaluated for the North America dermatological therapeutics market growth analysis.

NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028

North America Dermatological Therapeutics Market by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other Drug Classes) by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Acne Vulgaris, Other Applications) and by Geography.

Request free sample

The North America dermatological therapeutics market is estimated to project a CAGR of 7.40% during the forecast period, 2019-2028. The region encompasses a highly fragmented dermatology industry, and is estimated to get consolidated as a result of complexity and rising costs. Also, there is a rising demand for dermatology services.
North America Dermatological Therapeutics Market

To know more about this report, request a free sample copy

The United States and Canada are evaluated for the North America dermatological therapeutics market growth analysis. The US market growth is influenced by the growing geriatric population, latest product launches, and the increasing dermatological disorders. The skin disorder is one of the most common health issues in the country. Thus, the increasing numbers of the same are set to propel market growth. The increasing expenditure on dermatological treatments is projected to influence market growth prospects. Most skin disorders are linked to aging. Thus the rising aging population will impact the future of the market. Moreover, the presence of leading market players, and the subsequent product launches, activities, new drug developments, collaborations, etc. are set to be beneficial for the market during the forecast period. Brodalumab got FDA approval in February 2017 for treating moderate to severe plaque psoriasis in those who did not get any success in recovery from other treatments.

AbbVie Inc is a research-based biopharmaceutical company whose products are centered on treating conditions like chronic autoimmune diseases like rheumatology, dermatology, oncology, etc. The products are sold across the world. The company invests in key therapeutic areas like oncology, neuroscience, and immunology. The product portfolio of the company includes SKYRIZI and Upadacitinib.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISING LOAD OF DERMATOLOGY DISEASES
      • RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
    •    KEY RESTRAINTS
      • SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
  1. KEY ANALYTICS
    • KEY INVESTMENT INSIGHTS
    •    PORTER’S FIVE FORCE ANALYSIS
      • BUYER POWER
      • SUPPLIER POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  3. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS
  4. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ABBVIE INC
    • ALLERGAN INC
    • ALMIRAL
    • AMGEN INC
    • BAUSCH HEALTH COMPANIES INC
    • GALDERMA
    • GLAXOSMITHKLINE PLC
    • JOHNSON & JOHNSON
    • NOVARTIS AG
    • PFIZER INC
    • AGI DERMATICS
    • LEO PHARMA A/S
    • MERCK KGAA

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – DERMATOLOGICAL THERAPEUTICS

TABLE 2: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 3: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 4: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)

TABLE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)

TABLE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUG CLASS, IN 2019

FIGURE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 8: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 9: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 10: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 11: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 12: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019

FIGURE 13: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 14: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 15: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 16: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 17: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 18: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 19: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 20: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 21: UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

FIGURE 22: CANADA DERMATOLOGICAL THERAPEUTICS MARKET, 2019-2028 (IN $ BILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • UNITED STATES
      • CANADA
  1. MARKET BY DRUG CLASS
    • ANTI-INFECTIVES
    • CORTICOSTEROIDS
    • ANTI-ACNE
    • CALCINEURIN INHIBITORS
    • RETINOIDS
    • OTHER DRUG CLASSES
  2. MARKET BY APPLICATION
    • ALOPECIA
    • HERPES
    • PSORIASIS
    • ROSACEA
    • ATOPIC DERMATITIS
    • ACNE VULGARIS
    • OTHER APPLICATIONS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now